Genentech   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: South San Francisco CA United States (1976)
Status: Acquired by Roche (2009)

Organization Overview

First Clinical Trial
1985
NCT00097539
First Marketed Drug
1979
somatropin (protropin)
First NDA Approval
1985
growth hormone (protropin)
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

GENENTECH | Genentech and Biogen IDEC | Genentech, Inc. | GENENTECH INC | Genentech, Inc., University of Colorado Denver, National Jewish, Beth Israel Deaconess Medical Center, and Long Island Jewish Hospital | Genentech/Roche | Genentech (South San Francisco, California, USA) | Genetech